IBM’s Watson for Oncology is falling short of expectations. 

“Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it’s falling short of the lofty expectations IBM created for it.” After reading this, I feel like the criticisms are valid, but mostly a mismatch of marketing vs results rather than a permanent indictment of AI for healthcare. | learn more